Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 9,777,889
- Share change
- +556,822
- Total reported value
- $66,488,000
- Price per share
- $6.80
- Number of holders
- 35
- Value change
- +$3,712,599
- Number of buys
- 21
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
5.2%
|
3,085,458
|
$22,215,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
2.7%
|
1,611,311
|
$11,601,000 | — | 30 Sep 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.7%
|
1,044,131
|
$7,518,000 | — | 30 Sep 2017 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
835,514
|
$6,016,000 | — | 30 Sep 2017 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
750,000
|
$5,400,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.91%
|
545,085
|
$3,925,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.79%
|
471,031
|
$3,392,000 | — | 30 Sep 2017 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.21%
|
124,096
|
$893,000 | — | 30 Sep 2017 | |
| Hikari Power Ltd |
13F
|
Company |
0.18%
|
107,858
|
$777,000 | — | 30 Sep 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
85,200
|
$613,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
75,994
|
$547,000 | — | 30 Sep 2017 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.08%
|
50,728
|
$365,000 | — | 30 Sep 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.08%
|
50,000
|
$360,000 | — | 30 Sep 2017 | |
| WOODSTOCK CORP |
13F
|
Company |
0.08%
|
48,393
|
$348,000 | — | 30 Sep 2017 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
0.07%
|
39,552
|
$285,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
37,667
|
$271,000 | — | 30 Sep 2017 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.05%
|
29,650
|
$214,000 | — | 30 Sep 2017 | |
| ELLINGTON MANAGEMENT GROUP LLC |
13F
|
Company |
0.04%
|
23,300
|
$168,000 | — | 30 Sep 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
22,070
|
$159,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
18,570
|
$134,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
18,500
|
$133,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
17,267
|
$124,000 | — | 30 Sep 2017 | |
| DRW Securities, LLC |
13F
|
Company |
0.02%
|
12,000
|
$86,000 | — | 30 Sep 2017 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
10,961
|
$79,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
9,783
|
$71,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
8,000
|
$57,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
7,500
|
$54,000 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
3,400
|
$24,000 | — | 30 Sep 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,183
|
$23,000 | — | 30 Sep 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
1,612
|
$12,000 | — | 30 Sep 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,364
|
$10,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,264
|
$9,000 | — | 30 Sep 2017 | |
| AlphaOne Investment Services, LLC |
13F
|
Company |
0%
|
725
|
$5,000 | — | 30 Sep 2017 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
450
|
$3,000 | — | 30 Sep 2017 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q4 2017
As of 31 Dec 2017,
Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,777,889 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, SPHERA FUNDS MANAGEMENT LTD., 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, Vanguard Group Inc, ADAGE CAPITAL PARTNERS GP, L.L.C., MANGROVE PARTNERS, Knoll Capital Management, LP, and Hikari Power Ltd.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
35
Q4 2017 holders
35
Holder diff
0
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.